Mohamed Mohamoud

United States Food and Drug Administration

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Complementary Use of U.S. FDA’s Adverse Event Reporting System and Sentinel System to Characterize Direct Oral Anticoagulants‐Associated Cutaneous Small Vessel Vasculitis”.

Complementary Use of U.S. FDA’s Adverse Event Reporting System and Sentinel System to Characterize Direct Oral Anticoagulants‐Associated Cutaneous Small Vessel Vasculitis

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy(2020)10.1002/phar.2468

N/A

0DataRank · unranked

10 citations

Casie Horgan, Efe Eworuke, Elizabeth Dee, Justin Bohn, Oren Shapira +6 more

Acute Hyperkinetic Movement Disorders as a Multifactorial Pharmacodynamic Drug Interaction Between Methylphenidate and Risperidone in Children and Adolescents

Journal of Clinical Psychopharmacology(2022)10.1097/jcp.0000000000001547

N/A

0DataRank · unranked

6 citations

Qi Chen, David Croteau, Carmen Cheng, Keith Burkhart, Donna A. Volpe +4 more

A cohort study to assess risk of cutaneous small vessel vasculitis among users of different oral anticoagulants

Pharmacoepidemiology and Drug Safety(2022)10.1002/pds.5514

N/A

0DataRank · unranked

4 citations

Austin Cosgrove, Efe Eworuke, Mohamed Mohamoud, Rongmei Zhang, Oren Shapira +3 more

Pediatric Developmental Safety Assessment: Are We Ready for the Next Thalidomide?

Clinical Pharmacology & Therapeutics(2025)10.1002/cpt.70148

N/A

0DataRank · unranked

1 citations

Susan M. Abdel‐Rahman, Gelareh Abulwerdi, Sherbet Samuels, Rebecca Racz, Mohamed Mohamoud +2 more